- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6277
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Systemic Therapy for Metastatic Pancreatic Cancer ; volume:22 ; number:11 ; day:19 ; month:10 ; year:2021 ; pages:1-12 ; date:11.2021
Current treatment options in oncology ; 22, Heft 11 (19.10.2021), 1-12, 11.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11864-021-00895-4
- URN
-
urn:nbn:de:101:1-2022010518013557105757
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ettrich, Thomas J.
- Seufferlein, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
Systemic therapy for metastatic pancreatic cancer
SABCS 2016: systemic therapy for metastatic breast cancer
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
Systemic therapy in metastatic renal cell carcinoma
Systemic therapy for recurrent or metastatic salivary gland malignancies
Systemic therapy for hereditary cancer
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
Systemic treatment of metastatic breast cancer: SABCS 2018
Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays
Systemic therapy for metastatic pancreatic cancer
SABCS 2016: systemic therapy for metastatic breast cancer
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
Systemic therapy in metastatic renal cell carcinoma
Systemic therapy for recurrent or metastatic salivary gland malignancies
Systemic therapy for hereditary cancer
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
Systemic treatment of metastatic breast cancer: SABCS 2018
Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
The Current State of Systemic Therapy of Metastatic Uveal Melanoma
Systemic therapy of metastatic breast cancer: a plea for confirmation of subtypes by genomic assays
Systemic therapy for metastatic pancreatic cancer
SABCS 2016: systemic therapy for metastatic breast cancer
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer
Systemic therapy in metastatic renal cell carcinoma
Systemic therapy for recurrent or metastatic salivary gland malignancies
Systemic therapy for hereditary cancer
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
Systemic treatment of metastatic breast cancer: SABCS 2018
Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
The Current State of Systemic Therapy of Metastatic Uveal Melanoma